Consequently, the full-year EBITDA is now expected to realise in the lower end of the previous guidance range, i.e. EUR 184m and with a risk margin of +/- 10%. Regarding profit before tax, 2024 ...
The demand for medical services in China is growing, with the country’s ageing population set against its potential for economic development. A joint ...